Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuetiva Deming

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Aging Neuroscience|September 18, 2023
CSF metabolites associated with biomarkers of Alzheimer's disease pathologyRuocheng Dong, Qiongshi Lu, Hyunseung Kang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathologyVaibhav Vemuganti, Jea Woo Kang, Qijun Zhang, et al.
EMBO Molecular Medicine|August 14, 2020
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulationMichael Ewers, Gloria Biechele, Marc Suárez-Calvet, et al.
Plos Genetics|November 2, 2017
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer DiseaseMaria Victoria Fernández, Jong Hun Kim, John P Budde, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Factors associated with age at tau pathology onset and time from tau onset to dementiaMargo B Heston, Jordan P Teague, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 27, 2025
Factors associated with age at tau pathology onset and time from tau onset to dementia in Alzheimer's diseaseMargo B Heston, Jordan P Teague, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Elife|May 24, 2024
Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypesDonghui Yan, Bowen Hu, Burcu F Darst, et al.
Molecular Neurodegeneration|October 16, 2025
Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based studyMariana I Muñoz-García, Yuetiva Deming, Ferran Lugo-Hernández, et al.
Molecular Neurodegeneration|January 12, 2019
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathologyMarc Suárez-Calvet, Estrella Morenas-Rodríguez, Gernot Kleinberger, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Aging Neuroscience|September 18, 2023
CSF metabolites associated with biomarkers of Alzheimer's disease pathologyRuocheng Dong, Qiongshi Lu, Hyunseung Kang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathologyVaibhav Vemuganti, Jea Woo Kang, Qijun Zhang, et al.
EMBO Molecular Medicine|August 14, 2020
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulationMichael Ewers, Gloria Biechele, Marc Suárez-Calvet, et al.
Plos Genetics|November 2, 2017
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer DiseaseMaria Victoria Fernández, Jong Hun Kim, John P Budde, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Factors associated with age at tau pathology onset and time from tau onset to dementiaMargo B Heston, Jordan P Teague, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 27, 2025
Factors associated with age at tau pathology onset and time from tau onset to dementia in Alzheimer's diseaseMargo B Heston, Jordan P Teague, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Elife|May 24, 2024
Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypesDonghui Yan, Bowen Hu, Burcu F Darst, et al.
Molecular Neurodegeneration|October 16, 2025
Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based studyMariana I Muñoz-García, Yuetiva Deming, Ferran Lugo-Hernández, et al.
Molecular Neurodegeneration|January 12, 2019
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathologyMarc Suárez-Calvet, Estrella Morenas-Rodríguez, Gernot Kleinberger, et al.
Pageof 6